COMMUNIQUÉS West-GlobeNewswire

High Hampton Moves Forward with CoachellaGro Project -- CFN Media
03/08/2018
SEATTLE, Aug. 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
Grown Rogue Going Multi-State with Winning Functional Branding for Trusted Cannabis Experiences -- CFN Media
03/08/2018
Seattle, WA, Aug. 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
Canada's New Outdoor Grow Regulations Create New Risks, Opportunities -- CFN Media
03/08/2018
SEATTLE, Aug. 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
HTG Molecular Diagnostics and Oncologie, Inc. Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development
03/08/2018
TUCSON, Ariz., Aug. 03, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications and Oncologie, Inc. an [...]
Golden Leaf Holdings Management to Attend Upcoming Conferences in U.S. and Canada
03/08/2018
PORTLAND, Ore., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Teligent, Inc. to Hold Conference Call for Second Quarter 2018 Results
03/08/2018
BUENA, N.J., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Wednesday [...]
Athenex, Inc. to Report Second Quarter Earnings Results on August 14, 2018
03/08/2018
BUFFALO, N.Y., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Agile Therapeutics Reports Second Quarter 2018 Financial Results
03/08/2018
Cash Expected to Enable Company to Fund Operations into Second Quarter 2019 PRINCETON, N.J., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported [...]
Imke Casey, DNP, CRNA, RHIT is Elected to the American Health Council’s Nurse Board
03/08/2018
NEW YORK, Aug. 03, 2018 (GLOBE NEWSWIRE) -- The American Health Council recently elected Imke Casey, DNP, CRNA, RHIT to its Board of Nurses. Currently a nurse anesthetist at the Indian Health Services Department, an [...]
Nephros Schedules Second Quarter Financial Results Conference Call
03/08/2018
Call scheduled for Wednesday, August 8 th at 4:30 PM EDT SOUTH ORANGE, NJ, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high [...]
Tetra Bio-Pharma Provides Extension to North Bud Farms
03/08/2018
ORLEANS, Ontario, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that the company has provided [...]
U.S. Centers for Medicare and Medicaid Services (CMS) Grants New Technology Add-On Payment for Portola Pharmaceuticals’ Andexxa
03/08/2018
– Add-on payment to support patient access by providing additional Medicare reimbursement in the hospital setting – SOUTH SAN FRANCISCO, Calif. , Aug. 03, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq [...]
Cue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of Directors
03/08/2018
CAMBRIDGE, Mass., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ:CUE) a next-generation immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the [...]
CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
03/08/2018
--- Add-on Payment to Provide Additional Medicare Reimbursement up to 50% of the cost of ZEMDRI Prescribed to Medicare patients in Hospital Inpatient Setting --- SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE [...]
Spark Therapeutics Recognized for Second-straight Year as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal
03/08/2018
PHILADELPHIA, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that it has been [...]
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City
03/08/2018
RALEIGH, N.C., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases [...]
Oncolytics Biotech® Reports 2018 Second Quarter Results
03/08/2018
CALGARY, Alberta and SAN DIEGO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Aclaris Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments
03/08/2018
Management to Host Conference Call at 8:00 AM ET today WAYNE, Pa., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, [...]
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018
03/08/2018
RANCHO CUCAMONGA, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2018 ended June 30, 2018, after the [...]

Pages